Navigation Links
New Test for Diagnosing Attention-Deficit/Hyperactivity Disorder (ADHD)
Date:8/27/2013

Sturgeon Bay, WI (PRWEB) August 27, 2013

Attention-Deficit/Hyperactivity Disorder (ADHD) is a widespread neurobehavioral disorder seen in children and teens. It is characterized by inattention, impulsivity and behavioral difficulties, and/or over-activity not normal for one’s age group. Sturgeon Bay, Wisconsin Chiropractor and Naturopath Dr. J G Moellendorf, DC, ND, LCP states that the Centers for Disease Control and Prevention estimates 6.4 million American children have been diagnosed with ADHD, of which nearly 3 million are taking Ritalin, Adderall or other mind-altering drugs. This is a 41% increase in the last 10 years, which has led to many questions about the validity of the diagnosis.

Last month, the U.S. Food and Drug Administration (USDA) approved the first brain wave test to diagnose ADHD. This non-invasive 20-minute test has been authorized for use as part of a complete psychological exam of 6 to 17 year old patients to confirm or rule out a diagnosis of ADHD.

Nicknamed NEBA (Neuropsychiatric Interpretive Electroencephalograph Assessment Aid), it is the culmination of 7 years of research by a small start-up company of 10 people. Produced by NEBA Health of Augusta, Georgia, the device is already used in assessing sleep disorders, measuring unconsciousness, diagnosing the side e
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer
2. Market for Biologic Imaging Reagents and Medical Imaging & Diagnosing Analyzed in New Research Reports at ReportsnReports.com
3. Recently Published Economic Analysis Highlights the Financial Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) in the United States (US)
4. Pediatric Feeding Institute Revolutionizes the Treatment of Childrens Feeding Disorders with Mealtime Miseries Live Seminars
5. arGEN-X advances ARGX-113 into preclinical development for autoimmune disorders
6. In Focus with Martin Sheen Showcasing How Medication is Helping Win the Fight Against Mood Disorders
7. Combination of Key Nutrients Reduces Stress and Emotional Problems in Those with Attention Deficit Hyperactivity Disorder (ADHD) Research Shows
8. Intrinsically disordered proteins: A conversation with Rohit Pappu
9. ARMGO Pharma, Inc. announces data which supports its Rycal program as a novel approach for the treatment of stress-induced cognitive disorders
10. Lightlake Therapeutics Inc. Announces Positive Final Phase II Clinical Trial Results of Binge Eating Disorder Treatment
11. Vitamin D Deficiency Disorders Global Clinical Trials Review, H2, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... November 21, 2014 , ...   Mariano Rodríguez es elegid vicepresidente senior ... KLOX está en marcha para comenzar de forma rápida ... heridas de reciente aprobación en Europa   , ... complace al anunciar los siguientes nombramientos: Todd ...
(Date:11/21/2014)... The California Healthcare Institute ... representing leading California academic institutions, biotechnology, medical device, ... today released a report revealing that California ... The trend shows a 4 percent increase between ... Industry Report indicates that, while biopharmaceutical and ...
(Date:11/21/2014)... Dallas, Texas (PRWEB) November 21, 2014 ... China Sodium Ferrocyanide Industry” is a professional and ... it provides Sodium ferrocyanide information, like its ... well as industry overview. This report covers the ... well as global (such as the US, Europe, ...
(Date:11/21/2014)... , Nov. 20, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or ... month periods ended September 30, 2014.  Biorem,s complete 2014 third quarter ... ). Financial Summary:Three-months ended September 30, , ... share data) , 2014 , 2013 ... , 5,281 , 6,715 , ...
Breaking Biology Technology:KLOX Technologies anuncia sus nombramientos ejecutivos 2KLOX Technologies anuncia sus nombramientos ejecutivos 3KLOX Technologies anuncia sus nombramientos ejecutivos 4KLOX Technologies anuncia sus nombramientos ejecutivos 5California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 2California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 3California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 4Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 2Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 3Biorem Reports Third Quarter Results 2Biorem Reports Third Quarter Results 3
... ... The 2nd Algae World Europe conference in Brussels addresses ... engineering, marketing and financial aspects of the algae value chain. Panel ... biofuels and high-value co-products like pharmaceuticals, nutraceuticals, cosmetics, aquaculture feed, bioplastics, ...
... , , ... Ltd, a specialty,biopharmaceutical company focused on allergy, today announced ... in a,recently completed phase II clinical trial. Ragweed allergy ... of the population.,Circassia,s latest clinical results follow two earlier ...
... , , , , ... 3SBio Inc. (Nasdaq:, SSRX ), a leading biotechnology company ... in China ,today announced that it has submitted ... to the Chinese State Food and Drug Administration (SFDA).,NuPIAO ...
Cached Biology Technology:2nd Algae World Europe Tracks Algae Commercialization from Algae Production to High-value Products- Nutraceuticals, Aquaculture Feed, Cosmetics, Biofuels and More 22nd Algae World Europe Tracks Algae Commercialization from Algae Production to High-value Products- Nutraceuticals, Aquaculture Feed, Cosmetics, Biofuels and More 3Circassia Achieves Positive Phase II Clinical Results With Ragweed Allergy T-Cell Vaccine 2Circassia Achieves Positive Phase II Clinical Results With Ragweed Allergy T-Cell Vaccine 33SBio Inc. Submits Application for NuPIAO Phase I Clinical Trial 23SBio Inc. Submits Application for NuPIAO Phase I Clinical Trial 3
(Date:11/18/2014)...   EyeLock Inc. , a market leader ... USA (Safran), a leading U.S. provider of ... partnership to offer comprehensive biometric identity solutions and ... screening and financial services markets. As ... through a nationwide network of 1,100 IdentoGO® Centers.  ...
(Date:11/11/2014)... 11, 2014  Forensicon, Inc., a Chicago ... to announce the promotion of Yaniv Schiff ... Forensics. In Schiff,s new role as Director, he will ... digital forensics examiners and provide leadership within the company,s ... http://photos.prnewswire.com/prnh/20141110/157719 Schiff joined Forensicon ...
(Date:11/7/2014)... BURBANK, Calif. , Nov. 7, 2014  In conjunction ... Burbank Police Departments, The Community Foundation of the ... BURBANK DNA JUSTICE PROJECT," a $250,000 initiative to ... successful initial phase. In its first six months of existence, ... desperately needed evidence support for local law enforcement. ...
Breaking Biology News(10 mins):EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2Community Foundation Of The Verdugos Unveils Campaign To Fund Glendale-Burbank DNA Justice Project 2
... important new study assessing the demographic impact of the ... 60 prehistoric American cemeteries to prove that the invention ... birth rate. , Discussing the shifts in the ... in Europe at the end of the Stone Age, ...
... tools and cryo-electron microscopes, researchers at Baylor College of Medicine ... and, in doing so, opened the door to a better ... animals. , In a report that appears in and on ... Dr. Wah Chiu, professor in the BCM department of biochemistry ...
... Bioinformatics Institute (VBI) at Virginia Tech, Colorado State ... a new method to determine gene function on ... brassicicola. This destructive fungus causes black spot disease, ... important crops as canola, cabbage, and broccoli. ...
Cached Biology News:Unraveling the viral mechanism 2New method enables gene disruption in destructive fungal pathogen 2
... The four-bay DNA Engine Tetrad 2 ... interchangeable Alpha units (sample-holder, heat-pump assemblies), ... of vessels. A Pentium-class computer drives ... current block, sample, and lid temperatures. ...
4',6-Diamidino-2-phenylindole, dihydrochloride (DAPI)...
... has been developed with the drug discovery ... flexibility, sensitivity and performance, Safire is the ... assay development and high throughput screening. Safire ... system that offers a range of high ...
... cm, is used for vertical slab gel electrophoresis ... The cell is supplied without spacers and combs. ... gaskets, lower buffer chamber, lid with cables, 2 ... buffer dam, casting stand with gaskets, leveling bubble, ...
Biology Products: